Network of interactions significantly enriched for genes displaying altered methylation patterns following treatment with valeric acid. This network was identified by the IPA as being the most significantly associated with the set of input genes and molecules within this network have functional relevance in “RNA post-transcriptional modification, Cancer, and Developmental disorder” (p = 10E−59). Of the 27 genes present in the network, 26 were significantly hypermethylated are shaded in green, while only 1 was hypomethylated are shaded in red. Each interaction is supported by at least one literature reference identified in the Ingenuity Pathway Knowledge Base, with solid lines representing direct interactions, and dashed lines representing indirect interactions.
Description
Summary model of valerian and valeric acid mechanisms in breast cancer growth inhibition is presented, linking epigenetic modifications to downstream anti-proliferative effects.
Figure 6
DiagramSource Paper
Valerian and valeric acid inhibit growth of breast cancer cells possibly by mediating epigenetic modifications.Cite This Figure
 > Source: Fengqin Shi et al. "Valerian and valeric acid inhibit growth of breast cancer cells possibly by medi." *Scientific reports*, 2021. PMID: [33510252](https://pubmed.ncbi.nlm.nih.gov/33510252/)
<figure> <img src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844014/bin/41598_2021_81620_Fig6_HTML.jpg" alt="Summary model of valerian and valeric acid mechanisms in breast cancer growth inhibition is presented, linking epigenetic modifications to downstream anti-proliferative effects." /> <figcaption>Figure 6. Summary model of valerian and valeric acid mechanisms in breast cancer growth inhibition is presented, linking epigenetic modifications to downstream anti-proliferative effects.<br> Source: Fengqin Shi et al. "Valerian and valeric acid inhibit growth of breast cancer cells possibly by medi." <em>Scientific reports</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33510252/">33510252</a></figcaption> </figure>